Besides, our study findings revealed that BMP8B has high sensitivity and specificity in detecting NASH patients when compared with the other non-invasive biomarkers that are used in clinical settings in regular intervals. The gene discussed is BMP8B; the disease is metabolic dysfunction-associated steatohepatitis.